U.S. flag

An official website of the United States government

NM_003476.5(CSRP3):c.579_582del (p.Lys193fs) AND Hypertrophic cardiomyopathy

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 5, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003993829.1

Allele description [Variation Report for NM_003476.5(CSRP3):c.579_582del (p.Lys193fs)]

NM_003476.5(CSRP3):c.579_582del (p.Lys193fs)

Gene:
CSRP3:cysteine and glycine rich protein 3 [Gene - OMIM - HGNC]
Variant type:
Microsatellite
Cytogenetic location:
11p15.1
Genomic location:
Preferred name:
NM_003476.5(CSRP3):c.579_582del (p.Lys193fs)
HGVS:
  • NC_000011.10:g.19182675CTTT[1]
  • NG_011932.2:g.32894AGAA[1]
  • NM_001369404.1:c.410_413del
  • NM_003476.5:c.579_582delMANE SELECT
  • NP_001356333.1:p.Lys137fs
  • NP_003467.1:p.Lys193fs
  • LRG_440t1:c.579_582del
  • LRG_440:g.32894AGAA[1]
  • NC_000011.9:g.19204220_19204223delTTCT
  • NC_000011.9:g.19204222CTTT[1]
  • NM_003476.3:c.579_582delAGAA
  • NM_003476.5:c.579_582delAGAAMANE SELECT
  • p.Lys193AsnfsX14
Protein change:
K137fs
Links:
dbSNP: rs727502946
NCBI 1000 Genomes Browser:
rs727502946
Molecular consequence:
  • NM_001369404.1:c.410_413del - frameshift variant - [Sequence Ontology: SO:0001589]
  • NM_003476.5:c.579_582del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:
Hypertrophic cardiomyopathy
Synonyms:
HYPERTROPHIC MYOCARDIOPATHY
Identifiers:
MONDO: MONDO:0005045; MeSH: D002312; MedGen: C0007194; Human Phenotype Ontology: HP:0001639

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004812523Molecular Genetics, Royal Melbourne Hospital

See additional submitters

criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 5, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Molecular Genetics, Royal Melbourne Hospital, SCV004812523.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)

Description

This sequence change in CSRP3 is a frameshift variant, p.(Lys193Asnfs*14), in biologically relevant exon 6/6 that is predicted to escape nonsense-mediated decay and elongate the protein by 12 amino acids with an unknown effect on protein function. This variant is absent from the population database gnomAD v2.1 and v3.1. To our knowledge, this variant has not been previously reported in the relevant scientific literature. It has been reported as a variant of uncertain significance (ClinVar). Based on the classification scheme RMH Modified ACMG/AMP Guidelines v1.6.1, this variant is classified as a VARIANT OF UNCERTAIN SIGNIFICANCE. Following criteria are met: PVS1_Moderate, PM2_Supporting.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2024